Cited by 376Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchGenetic Associations and Epidemiology

The DOI matches its Crossref record; 69 of the 71 references it cites were found in a registry or an index.

Hippocampal Atrophy as a Quantitative Trait in a Genome-Wide Association Study Identifying Novel Susceptibility Genes for Alzheimer's Disease

Open access

Potkin, Steven G., Guffanti, Guia, Lakatos, Anita, Turner, Jessica A., Kruggel, Frithjof, Fallon, James H., Saykin, Andrew J., Orro, Alessandro, Lupoli, Sara, Salvi, Erika, Weiner, Michael, Macciardi, Fabio, for the Alzheimer's Disease Neuroimaging Initiative·2009·PLoS ONE

DOI 10.1371/journal.pone.0006501PMC PMC2719581

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: With the exception of APOE epsilon4 allele, the common genetic risk factors for sporadic Alzheimer's Disease (AD) are unknown. METHODS AND FINDINGS: We completed a genome-wide association study on 381 participants in the ADNI (Alzheimer's Disease Neuroimaging Initiative) study. Samples were genotyped using the Illumina Human610-Quad BeadChip. 516,645 unique Single Nucleotide Polymorphisms (SNPs) were included in the analysis following quality control measures. The genotype data and raw genetic data are freely available for download (LONI, http://www.loni.ucla.edu/ADNI/Data/). Two analyses were completed: a standard case-control analysis, and a novel approach using hippocampal atrophy measured on MRI as an objectively defined, quantitative phenotype. A General Linear Model was applied to identify SNPs for which there was an interaction between the genotype and diagnosis on the quantitative trait. The case-control analysis identified APOE and a new risk gene, TOMM40 (translocase of outer mitochondrial membrane 40), at a genome-wide significance level of < or =10(-6) (10(-11) for a haplotype). TOMM40 risk alleles were approximately twice as frequent in AD subjects as controls. The quantitative trait analysis identified 21 genes or chromosomal areas with at least one SNP with a p-value < or =10(-6), which can be considered potential "new" candidate loci to explore in the etiology of sporadic AD. These candidates included EFNA5, CAND1, MAGI2, ARSB, and PRUNE2, genes involved in the regulation of protein degradation, apoptosis, neuronal loss and neurodevelopment. Thus, we identified common genetic variants associated with the increased risk of developing AD in the ADNI cohort, and present publicly available genome-wide data. Supportive evidence based on case-control studies and biological plausibility by gene annotation is provided. Currently no available sample with both imaging and genetic data is available for replication. CONCLUSIONS: Using hippocampal atrophy as a quantitative phenotype in a genome-wide scan, we have identified candidate risk genes for sporadic Alzheimer's disease that merit further investigation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0006501

Cites

69 of 69 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single subject brain
Tzourio-Mazoyer, N., Landeau, B., Papathanassiou, D., Crivello, F., Etard, O., Delcroix, N., Mazoyer, B., & Joliot, M. (2002) · NeuroImage · doi:10.1006/nimg.2001.0978 · Cited by 16,319
Haploview: analysis and visualization of LD and haplotype maps
Barrett, J. C., Fry, B., Maller, J., & Daly, M. J. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bth457 · Cited by 14,551
Advances in functional and structural MR image analysis and implementation as FSL
Smith, S. M., Jenkinson, M., Woolrich, M. W., Beckmann, C. F., Behrens, T. E. J., Johansen-Berg, H., Bannister, P. R., De Luca, M., Drobnjak, I., Flitney, D. E., et al. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2004.07.051 · Cited by 13,630
Principal components analysis corrects for stratification in genome-wide association studies
Price, A. L., Patterson, N. J., Plenge, R. M., Weinblatt, M. E., Shadick, N. A., & Reich, D. (2006) · Nature Genetics · doi:10.1038/ng1847 · Cited by 10,248
Voxel-Based Morphometry—The Methods
Ashburner, J., & Friston, K. J. (2000) · NeuroImage · doi:10.1006/nimg.2000.0582 · Cited by 8,676
A second generation human haplotype map of over 3.1 million SNPs
The International HapMap Consortium (2007) · Nature · doi:10.1038/nature06258 · Cited by 4,438
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria
Dubois, B., Feldman, H. H., Jacova, C., DeKosky, S. T., Barberger-Gateau, P., Cummings, J., Delacourte, A., Galasko, D., Gauthier, S., Jicha, G., et al. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70178-3 · Cited by 4,411
The Alzheimer’s disease neuroimaging initiative (ADNI): MRI methods
Jack, C. R., Bernstein, M. A., Fox, N. C., Thompson, P., Alexander, G., Harvey, D., Borowski, B., Britson, P. J., L. Whitwell, J., Ward, C., et al. (2008) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21049 · Cited by 4,347
Genome-wide association studies for common diseases and complex traits
Hirschhorn, J. N., & Daly, M. J. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1521 · Cited by 2,923

Flagged first, then by citations

Show all 71 references

2 of the 71 references couldn’t be matched to a known paper.

Sorted by citations

Epidemiology of Alzheimer disease
Reitz, C., Brayne, C., & Mayeux, R. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.2 · Cited by 1,675
Epidemiology of Alzheimer DiseasePreprint
Mayeux, R. P., & Stern, Y. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006239 · Cited by 1,127
The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception
Weiner, M. W., Veitch, D. P., Aisen, P. S. S., Beckett, L. A., Cairns, N. J., Green, R. C., Harvey, D. J., Jack, C. R., Jagust, W. J., Liu, E., et al. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.05.1769 · Cited by 1,033
The Genetics of Alzheimer Disease: Back to the Future
Bertram, L., Lill, C. M., & Tanzi, R. E. (2010) · Neuron · doi:10.1016/j.neuron.2010.10.013 · Cited by 834
The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data
the Alzheimer’s Disease Neuroimaging Initiative, E. C., Thompson, P. M., Stein, J. L., Medland, S. E., Hibar, D. P., Vasquez, A. A., Renteria, M. E., Toro, R., Jahanshad, N., Schumann, G., et al. (2014) · Brain Imaging and Behavior · doi:10.1007/s11682-013-9269-5 · Cited by 838
Self-citation
The Alzheimer’s disease mitochondrial cascade hypothesis: progress and perspectives
Swerdlow, R. H., Burns, J. M., & Khan, S. M. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.09.010 · Cited by 786
The Genetics of Alzheimer's Disease
Bertram, L., & Tanzi, R. E. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385883-2.00008-4 · Cited by 794
The Alzheimer's Disease Neuroimaging Initiative: Progress report and future plans
Weiner, M. W., Aisen, P. S. S., Jack, C. R., Jagust, W. J., Trojanowski, J. Q., Shaw, L. M. J., Saykin, A. J., Morris, J. C., Cairns, N. J., Beckett, L. A., et al. (2010) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.03.007 · Cited by 613
The Alzheimer’s Disease Mitochondrial Cascade Hypothesis
Swerdlow, R. H., Burns, J. M., & Khan, S. M. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100339 · Cited by 562
“It now appears polymorphisms in a neighboring gene, TOMM40, associate with AD risk [99, 100,101].”
Background
The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception
Weiner, M. W., Veitch, D. P., Aisen, P. S. S., Beckett, L. A., Cairns, N. J., Green, R. C., Harvey, D. J., Jack, C. R., Jagust, W. J., Liu, E., et al. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.09.172 · Cited by 497
Alzheimer’s Disease Genetics: From the Bench to the Clinic
Karch, C. M., Cruchaga, C., & Goate, A. M. (2014) · Neuron · doi:10.1016/j.neuron.2014.05.041 · Cited by 473
Genetic signatures of exceptional longevity in humans
Sebastiani, P., Solovieff, N., DeWan, A. T., Walsh, K. M., Puca, A., Hartley, S. W., Melista, E., Andersen, S., Dworkis, D. A., Wilk, J. B., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029848 · Cited by 464
Alzheimer’s Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans
Saykin, A. J., Shen, L., Foroud, T. M., Potkin, S. G., Swaminathan, S., Kim, S., Risacher, S. L., Nho, K., Huentelman, M. J., Craig, D. W., et al. (2010) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2010.03.013 · Cited by 442
A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease
Roses, A. D., Lutz, M. W., Amrine‐Madsen, H., Saunders, A. M., Crenshaw, D. G., Sundseth, S. S., Huentelman, M. J., Welsh-Bohmer, K. A., & Reiman, E. M. (2009) · The Pharmacogenomics Journal · doi:10.1038/tpj.2009.69 · Cited by 391
Whole genome association study of brain-wide imaging phenotypes for identifying quantitative trait loci in MCI and AD: A study of the ADNI cohort
Shen, L., Kim, S., Risacher, S. L., Nho, K. T., Swaminathan, S., West, J. D., Foroud, T., Pankratz, N., Moore, J. H., Sloan, C., et al. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.01.042 · Cited by 383
2014 Update of the Alzheimer’s Disease Neuroimaging Initiative: A review of papers published since its inception
Weiner, M. W., Veitch, D. P., Aisen, P. S., Beckett, L. A., Cairns, N. J., Cedarbaum, J., Green, R. C., Harvey, D., Jack, C. R., Jagust, W., et al. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.11.001 · Cited by 348
Self-citation
Genes associated with Alzheimer's disease: an overview and current status
Giri, M., Lü, Y., & Zhang, M. (2016) · Clinical Interventions in Aging · doi:10.2147/cia.s105769 · Cited by 311
Genetic studies of quantitative MCI and AD phenotypes in ADNI: Progress, opportunities, and plans
Saykin, A. J., Shen, L., Yao, X., Kim, S., Nho, K. T., Risacher, S. L., Ramanan, V. K., Foroud, T., Faber, K. M., Sarwar, N., et al. (2015) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2015.05.009 · Cited by 307
A mitochondrial etiology of Alzheimer and Parkinson disease
Coskun, P. E., Wyrembak, J., Schriner, S. E., Chen, H.-W., Marciniack, C., LaFerla, F. M., & Wallace, D. C. (2011) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.08.008 · Cited by 297
Voxelwise genome-wide association study (vGWAS)
Stein, J. L., Hua, X., Lee, S., Ho, A. J., Leow, A., Toga, A. W., Saykin, A. J., Shen, L., Foroud, T., Pankratz, N., et al. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.02.032 · Cited by 276
Multilocus Genetic Profile for Dopamine Signaling Predicts Ventral Striatum Reactivity
Nikolova, Y. S., Ferrell, R. E., Manuck, S. B., & Hariri, A. R. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.82 · Cited by 274
Genome-wide association studies in Alzheimer’s disease
Bertram, L., & Tanzi, R. E. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp406 · Cited by 257
Genetics of familial and sporadic Alzheimer s disease
Piaceri, I. (2013) · Frontiers in Bioscience · doi:10.2741/e605 · Cited by 256
Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014
Weiner, M. W., Veitch, D. P., Aisen, P. S. S., Beckett, L. A., Cairns, N. J., Cedarbaum, J. M., Donohue, M., Green, R. C., Harvey, D. J., Jack, C. R., et al. (2015) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2015.04.005 · Cited by 249
Sex and age differences in atrophic rates: an ADNI study with n=1368 MRI scans
Hua, X., Hibar, D. P., Lee, S., Toga, A. W., Jack, C. R., Weiner, M. W., & Thompson, P. M. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.033 · Cited by 234
Self-citation
Genome-Wide Association of Familial Late-Onset Alzheimer's Disease Replicates BIN1 and CLU and Nominates CUGBP2 in Interaction with APOE
Wijsman, E. M., Pankratz, N., Choi, Y., Rothstein, J. H., Faber, K. M., Cheng, R., Lee, J. H., Bird, T. D., Bennett, D. A., Diaz-Arrastia, R. R., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1001308 · Cited by 229
Genetic Variation and Neuroimaging Measures in Alzheimer Disease
Biffi, A. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.108 · Cited by 222
Epidemiology and Etiology of Alzheimer’s disease: From Genetic to Non- Genetic Factors
Jiang, T., Yu, J., Tian, Y., & Tan, L. (2013) · Current Alzheimer Research · doi:10.2174/15672050113109990155 · Cited by 231
Genome-wide association study of CSF biomarkers Aβ 1-42 , t-tau, and p-tau 181p in the ADNI cohort
Kim, S., Swaminathan, S., Shen, L., Risacher, S. L., Nho, K., Foroud, T., Shaw, L. M., Trojanowski, J. Q., Potkin, S. G., Huentelman, M. J., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e318204a397 · Cited by 206
The role of mitochondrial dysfunction in age-related diseases
Lane, R. K., Hilsabeck, T., & Rea, S. L. (2015) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2015.05.021 · Cited by 205
Mitochondria and Cell Bioenergetics: Increasingly Recognized Components and a Possible Etiologic Cause of Alzheimer's Disease
Swerdlow, R. H. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4149 · Cited by 206
The challenges and promise of neuroimaging in psychiatry.
Linden, D. (2012) · Neuron · doi:10.1016/j.neuron.2011.12.014 · Cited by 207
The paradox of syndromic diversity in Alzheimer disease
Warren, J. D., Fletcher, P. D., & Golden, H. L. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.135 · Cited by 204
Hippocampal sclerosis of aging, a prevalent and high-morbidity brain disease
Nelson, P. T., Smith, C. D., Abner, E. L., Wilfred, B. R., Wang, W., Neltner, J. H., Baker, M., Fardo, D. W., Kryscio, R. J., Scheff, S. W., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1154-1 · Cited by 201
Different patterns of gray matter atrophy in early- and late-onset Alzheimer’s disease
Möller, C., Vrenken, H., Jiskoot, L. C., Versteeg, A., Barkhof, F., Scheltens, P., & van der Flier, W. M. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.02.013 · Cited by 187
Genomic variants, genes, and pathways of Alzheimer's disease: An overview
Naj, A. C., & Schellenberg, G. D. (2016) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32499 · Cited by 186
Genetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkers
Initiative, A. D. N., Shen, L., Thompson, P. M., Potkin, S. G., Bertram, L., Farrer, L. A., Foroud, T., Green, R. C., Hu, X., Huentelman, M. J., et al. (2013) · Brain Imaging and Behavior · doi:10.1007/s11682-013-9262-z · Cited by 176
Meta-Analysis for Genome-Wide Association Study Identifies Multiple Variants at the BIN1 Locus Associated with Late-Onset Alzheimer's Disease
Hu, X., Pickering, E. H., Liu, Y. C., Hall, S., Fournier, H., Katz, E., DeChairo, B. M., John, S., Eerdewegh, P. V., Soares, H. D., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016616 · Cited by 167
Systemic Mitochondrial Dysfunction and the Etiology of Alzheimer's Disease and Down Syndrome Dementia
Coskun, P. E., Wyrembak, J., Derbereva, O., Melkonian, G., Doran, E. W., Lott, I. T., Head, E., Cotman, C. W., & Wallace, D. C. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100351 · Cited by 161
Neuronal Calcium Signaling, Mitochondrial Dysfunction, and Alzheimer's Disease
Supnet, C. B., & Борисович, Б. И. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100306 · Cited by 166
Innate immune inflammatory cell death: PANoptosis and PANoptosomes in host defense and disease
Chen, W., Gullett, J. M., Tweedell, R. E., & Kanneganti, T. (2023) · European Journal of Immunology · doi:10.1002/eji.202250235 · Cited by 161
Genome-wide association with MRI atrophy measures as a quantitative trait locus for Alzheimer’s disease
Furney, S. J., Simmons, A., Breen, G., Pedroso, I., Lunnon, K., Proitsi, P., Hodges, A., Powell, J., Wahlund, L.-O., Kloszewska, I., et al. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.123 · Cited by 157
Genetics of the connectome
Thompson, P. M., Ge, T., Glahn, D. C., Jahanshad, N., & Nichols, T. E. (2013) · NeuroImage · doi:10.1016/j.neuroimage.2013.05.013 · Cited by 159
Neuroimaging and Other Biomarkers for Alzheimer's Disease: The Changing Landscape of Early Detection
Risacher, S. L., & Saykin, A. J. (2013) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-050212-185535 · Cited by 163
The APOE ɛ4 allele modulates brain white matter integrity in healthy adults
Heise, V, Filippini, N., Ebmeier, K. P., & Mackay, C. E. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.90 · Cited by 152
Increased brain atrophy rates in cognitively normal older adults with low cerebrospinal fluid Aβ1‐42
Schott, J. M., Bartlett, J. W., Fox, N. C., Barnes, J., & Initiative, A. D. N. (2010) · Annals of Neurology · doi:10.1002/ana.22315 · Cited by 146
Genetic Signatures of Exceptional Longevity in Humans
Sebastiani, P., Solovieff, N., Puca, A., Hartley, S. W., Melista, E., Andersen, S., Dworkis, D. A., Wilk, J. B., Myers, R. H., Steinberg, M. H., et al. (2010) · Science · doi:10.1126/science.1190532 · Cited by 141
Retracted
Sparse reduced-rank regression detects genetic associations with voxel-wise longitudinal phenotypes in Alzheimer's disease
Vounou, M., Janoušová, E., Wolz, R., Stein, J. L., Thompson, P. M., Rueckert, D., & Montana, G. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.12.029 · Cited by 147
Patterns of Genome-Wide VDR Locations
Tuoresmäki, P., Vaïsänen, S., Neme, A., Heikkinen, S., & Carlberg, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096105 · Cited by 141
The Association between a Polygenic Alzheimer Score and Cortical Thickness in Clinically Normal Subjects
Sabuncu, M. R., Buckner, R. L., Smoller, J. W., Lee, P. H., Fischl, B. R., & Sperling, R. A. (2011) · Cerebral Cortex · doi:10.1093/cercor/bhr348 · Cited by 134
Methylation differences at the HLA-DRB1 locus in CD4+ T-Cells are associated with multiple sclerosis
Graves, M. C., Benton, M. C., Lea, R. A., Boyle, M., Tajouri, L., Macartney-Coxson, D. P., Scott, R. J., & Lechner‐Scott, J. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458513516529 · Cited by 131
Voxelwise gene-wide association study (vGeneWAS): Multivariate gene-based association testing in 731 elderly subjects
Hibar, D. P., Stein, J. L., Omid Kohannim, A., Jahanshad, N., Saykin, A. J., Shen, L., Kim, S., Pankratz, N., Foroud, T., Huentelman, M. J., et al. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.03.077 · Cited by 132
Whole-genome analyses of whole-brain data: working within an expanded search space
Medland, S. E., Jahanshad, N., Neale, B. M., & Thompson, P. M. (2014) · Nature Neuroscience · doi:10.1038/nn.3718 · Cited by 119
A review of multivariate analyses in imaging genetics
Liu, J., & Calhoun, V. D. (2014) · Frontiers in Neuroinformatics · doi:10.3389/fninf.2014.00029 · Cited by 132
Genetic architecture of Alzheimer's disease
Neuner, S. M., TCW, J., & Goate, A. M. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104976 · Cited by 126
“…previously implicated in AD (including APOE and PICALM (Furney et al., 2011)) have been associated with imaging endophenotypes, a large number of novel loci and genes have been nominated by these analyses (Risacher et al., 2009; Furney et al., 2011; Potkin et al., 2009; Stein et al., 2010) (Fig.”
Background
A large scale multivariate parallel ICA method reveals novel imaging–genetic relationships for Alzheimer's disease in the ADNI cohort
Meda, S. A., Narayanan, B., Liu, J., Perrone-Bizzozero, N. I., Stevens, M. C., Calhoun, V. D., Glahn, D. C., Shen, L., Risacher, S. L., Saykin, A. J., et al. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2011.12.076 · Cited by 115
Associations of the Top 20 Alzheimer Disease Risk Variants With Brain Amyloidosis
Apostolova, L. G., Risacher, S. L., Duran, T., Stage, E., Goukasian, N., West, J. D., Do, T. M., Grotts, J. F., Wilhalme, H. M., Nho, K. T., et al. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2017.4198 · Cited by 130
Discovery and replication of gene influences on brain structure using LASSO regression
Omid Kohannim, A. (2012) · Frontiers in Neuroscience · doi:10.3389/fnins.2012.00115 · Cited by 114
Identifying gene regulatory networks in schizophrenia
Potkin, S. G., Macciardi, F. M., Guffanti, G., Fallon, J. H., Wang, Q., Turner, J. A., Lakatos, A., Miles, M. F., Lander, A. D., Vawter, M. P., et al. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.06.036 · Cited by 113
The effect of TOMM40 poly‐T length on gray matter volume and cognition in middle‐aged persons with APOEɛ 3/ɛ 3 genotype
Johnson, S. C., La Rue, A., Hermann, B. P., Xu, G., Koscik, R. L., Jonaitis, E. M., Bendlin, B. B., Hogan, K. J., Roses, A. D., Saunders, A. M., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2010.11.012 · Cited by 112
Mitochondria, Cybrids, Aging, and Alzheimer's Disease
Swerdlow, R. H., Koppel, S., Weidling, I., Hayley, C., Ji, Y., & Wilkins, H. M. (2017) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2016.12.017 · Cited by 106
A decade in psychiatric GWAS research
Horwitz, T. B., Lam, K., Chen, Y., Xia, Y., & Liu, C. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0055-z · Cited by 108
Genome-wide significant risk factors for Alzheimer’s disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment
Lacour, A., Espinosa, A., Louwersheimer, E., Heilmann, S., Hernández, I., Wolfsgruber, S., Fernández, V, Wagner, H., Rosende-Roca, M., Mauleón, A., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.18 · Cited by 101
Neurogenetics of depression: A focus on reward processing and stress sensitivity
Bogdan, R., Nikolova, Y. S., & Pizzagalli, D. A. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.05.007 · Cited by 114
Alzheimer's disease genetics: current knowledge and future challenges
Hollingworth, P., Harold, D. H., Jones, L., Owen, M. J., & Williams, J. H. (2010) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2628 · Cited by 106
Functional analysis of APOE locus genetic variation implicates regional enhancers in the regulation of both TOMM40 and APOE
Bekris, L. M., Lutz, F., & Yu, C. (2011) · Journal of Human Genetics · doi:10.1038/jhg.2011.123 · Cited by 99
Imaging genomics
Thompson, P. M., Martin, N. G., & Wright, M. J. (2010) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32833b764c · Cited by 103
Relations between brain tissue loss, CSF biomarkers, and the ApoE genetic profile: a longitudinal MRI study
Tosun, D., Schuff, N. W., Truran‐Sacrey, D., Shaw, L. M. J., Trojanowski, J. Q., Aisen, P. S. S., Peterson, R., & Weiner, M. W. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.030 · Cited by 99
Association between mitochondrial DNA variations and Alzheimer's disease in the ADNI cohort
Lakatos, A., Derbeneva, O. A., Younes, D., Keator, D. B., Bakken, T. E., Lvova, M., Brandon, M. C., Guffanti, G., Reglődi, D., Saykin, A. J., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.031 · Cited by 97
Systematic tissue-specific functional annotation of the human genome highlights immune-related DNA elements for late-onset Alzheimer’s disease
Lu, Q., Powles, R. L., Abdallah, S., Ou, D., Wang, Q., Hu, Y., Lu, Y., Liu, W., Li, B., Mukherjee, S., et al. (2017) · PLOS Genetics · doi:10.1371/journal.pgen.1006933 · Cited by 97
Molecular and functional signatures in a novel Alzheimer’s disease mouse model assessed by quantitative proteomics
Kim, D. K., Park, J., Han, D., Yang, J., Kim, A., Woo, J., Kim, Y., & Mook-Jung, I. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0234-4 · Cited by 95
Genome-wide association reveals genetic effects on human Aβ 42 and τ protein levels in cerebrospinal fluids: a case control study
Han, M.-R., Schellenberg, G. D., Wang, L.-S., & Initiative, T. A. D. N. (2010) · BMC Neurology · doi:10.1186/1471-2377-10-90 · Cited by 93
Dysregulated microRNAs in neurodegenerative disorders
Lau, P., & Strooper, B. D. (2010) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2010.01.009 · Cited by 93
An Overview of Genome-Wide Association Studies in Alzheimer’s Disease
Shen, L., & Jia, J. (2016) · Neuroscience Bulletin · doi:10.1007/s12264-016-0011-3 · Cited by 93
Repositioning Microtubule Stabilizing Drugs for Brain Disorders
Varidaki, A., Hong, Y., & Coffey, E. T. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00226 · Cited by 93
Increasing power for voxel-wise genome-wide association studies: The random field theory, least square kernel machines and fast permutation procedures
Ge, T., Feng, J., Hibar, D. P., Thompson, P. M., & Nichols, T. E. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.07.012 · Cited by 88
Detecting genetic associations with brain imaging phenotypes in Alzheimer’s disease via a novel structured SCCA approach
Du, L., Liu, K., Yao, X., Risacher, S. L., Han, J., Saykin, A. J., Guo, L., & Shen, L. (2020) · Medical Image Analysis · doi:10.1016/j.media.2020.101656 · Cited by 88
Role of imaging in the era of precision medicine
Giardino, A., Gupta, S., Olson, E., Sepulveda, K., Lenchik, L., Ivanidze, J., Rakow-Penner, R., Patel, M. J., Subramaniam, R. M., & Ganeshan, D. (2017) · Academic Radiology · doi:10.1016/j.acra.2016.11.021 · Cited by 87
Introduction to special issue: Overview of Alzheimer's Disease Neuroimaging Initiative
Weiner, M. W., & Veitch, D. P. (2015) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2015.05.007 · Cited by 85
Identification of gene pathways implicated in Alzheimer's disease using longitudinal imaging phenotypes with sparse regression
Silver, M. J., Janoušová, E., Hua, X., Thompson, P. M., & Montana, G. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.08.002 · Cited by 86
Large-scale methylation domains mark a functional subset of neuronally expressed genesPreprint
Schroeder, D. I., Lott, P. C., Korf, I. F., & LaSalle, J. M. (2011) · Genome Research · doi:10.1101/gr.119131.110 · Cited by 87
Imaging genetics of mood disorders
Scharinger, C., Rabl, U., Sitte, H. H., & Pezawas, L. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.02.019 · Cited by 88
A neurogenetics approach to understanding individual differences in brain, behavior, and risk for psychopathology
Bogdan, R., Hyde, L. W., & Hariri, A. R. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.35 · Cited by 84
Genome-wide analysis of genetic predisposition to Alzheimer’s disease and related sex disparities
Nazarian, A., Yashin, A. I., & Kulminski, A. M. (2019) · Alzheimer s Research & Therapy · doi:10.1186/s13195-018-0458-8 · Cited by 82
Blood-based biomarkers for Alzheimer's disease: plasma Aβ40 and Aβ42, and genetic variants
Mayeux, R. P., & Schupf, N. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.09.004 · Cited by 79
Reduced sample sizes for atrophy outcomes in Alzheimer's disease trials: baseline adjustment
Schott, J. M., Bartlett, J. W., Barnes, J., Leung, K. K., Sebastien Ourselin, A., & Fox, N. C. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.011 · Cited by 82
Journal of Parkinson’s disease & Alzheimer’s disease
Gottschalk, W. K., Lutz, M. W., He, Y. T., Saunders, A. M., Burns, D. K., Roses, A. D., & Chiba‐Falek, O. (2014) · Journal of Parkinson’s Disease and Alzheimer’s Disease · doi:10.13188/2376-922x.1000003 · Cited by 80
Insight in Genome-Wide Association of Metabolite Quantitative Traits by Exome Sequence Analyses
Demirkan, A., Henneman, P., Verhoeven, A., Dharuri, H. K., Amin, N., van Klinken, J. B., Karssen, L. C., de Vries, B., Meissner, A., Göraler, S., et al. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1004835 · Cited by 77
Blood biomarkers for memory: toward early detection of risk for Alzheimer disease, pharmacogenomics, and repurposed drugs
Niculescu, A. B., Le-Niculescu, H., Roseberry, K., Wang, S., Hart, J. E., Kaur, A., Robertson, H., Jones, T., Strasburger, A. M., Williams, A., et al. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0602-2 · Cited by 76
A novel microdeletion syndrome at 9q21.13 characterised by mental retardation, speech delay, epilepsy and characteristic facial features
Boudry‐Labis, E., Demeer, B., Caignec, C. L., Isidor, B., Mathieu‐Dramard, M., Plessis, G., George, A. M., Taylor, J. P., Aftimos, S. F., Wiemer‐Kruel, A., et al. (2012) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2012.12.006 · Cited by 74
Genetic study of multimodal imaging Alzheimer’s disease progression score implicates novel loci
Scelsi, M. A., Khan, R. R., Lorenzi, M., Christopher, L., Greicius, M. D., Schott, J. M., Ourselin, S., & Altmann, A. (2018) · Brain · doi:10.1093/brain/awy141 · Cited by 73
Biomarkers in Alzheimer's Disease: Past, Present and Future
Gustaw‐Rothenberg, K., Lerner, A. J., Bonda, D., Lee, H., Zhu, X., Perry, G. L., & Smith, M. A. (2010) · Biomarkers in Medicine · doi:10.2217/bmm.09.86 · Cited by 71
Multidimensional heritability analysis of neuroanatomical shape
Ge, T., Reuter, M., Winkler, A. M., Holmes, A. J., Lee, P. H., Tirrell, L. S., Roffman, J. L., Buckner, R. L., Smoller, J. W., & Sabuncu, M. R. (2016) · Nature Communications · doi:10.1038/ncomms13291 · Cited by 76
Preclinical AD Workgroup staging: Pathological correlates and potential challenges
Jicha, G. A., Abner, E. L., Schmitt, F. A., Kryscio, R. J., Riley, K. P., Cooper, G. E., Stiles, N., Mendiondo, M. S., Smith, C. D., Van Eldik, L. J., et al. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.02.018 · Cited by 71
Dissecting Complex and Multifactorial Nature of Alzheimer’s Disease Pathogenesis: a Clinical, Genomic, and Systems Biology Perspective
Talwar, P., Sinha, J., Grover, S., Rawat, C., Kushwaha, S. S., Agarwal, R., Taneja, V., & Kukreti, R. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9390-0 · Cited by 71
Genetic, Transcriptome, Proteomic, and Epidemiological Evidence for Blood-Brain Barrier Disruption and Polymicrobial Brain Invasion as Determinant Factors in Alzheimer’s Disease
Carter, C. (2017) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-170017 · Cited by 74
Serotonin transporter gene polymorphisms and brain function during emotional distraction from cognitive processing in posttraumatic stress disorder
Morey, R. A., Hariri, A. R., Gold, A. L., Hauser, M. A., Munger, H., Dolcos, F., & McCarthy, G. (2011) · BMC Psychiatry · doi:10.1186/1471-244x-11-76 · Cited by 67
Genome-wide pathway analysis of memory impairment in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) cohort implicates gene candidates, canonical pathways, and networks
Initiative, A. D. N., Ramanan, V. K., Kim, S., Nudelman, K. N. H., Shen, L., Nho, K. T., Risacher, S. L., Foroud, T., Mukherjee, S., Crane, P. K., et al. (2012) · Brain Imaging and Behavior · doi:10.1007/s11682-012-9196-x · Cited by 66
δ-Catenin Is Genetically and Biologically Associated with Cortical Cataract and Future Alzheimer-Related Structural and Functional Brain Changes
Jun, G., Moncaster, J. A., Koutras, C., Seshadri, S. S., Buros, J. L., McKee, A. C., Lévesque, G., Wolf, P. A., George‐Hyslop, P. S., Goldstein, L. E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043728 · Cited by 66
Evaluation of late-onset Alzheimer disease genetic susceptibility risks in a Canadian population
Omoumi, A., Fok, A., Greenwood, T., Sadovnick, A. D., Feldman, H., & Hsiung, G. R. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.09.025 · Cited by 64

Authors: Potkin, S. G., Guffanti, G., Lakatos, A., Turner, J. A., Kruggel, F., Fallon, J. H., Saykin, A. J., Orro, A., Lupoli, S., Salvi, E., Weiner, M., Macciardi, F., & Initiative, F. T. A. D. N.
Affiliations: University of California, Irvine (US)
University of Milan (IT)
Indiana University Indianapolis (US)
Institute of Biomedical Technologies (IT)
Vita-Salute San Raffaele University (IT)
University of California, San Francisco (US)
Corresponding author: Potkin, Steven G.
ORCID: Potkin, Steven G.
Lakatos, Anita
Turner, Jessica A.
Kruggel, Frithjof
Saykin, Andrew J.
Orro, Alessandro
Salvi, Erika
Weiner, Michael
Macciardi, Fabio
Venue: PLoS ONE
Publisher: Public Library of Science (PLoS)
Published: 2009-08-07
Volume: 4
Issue: 8
Pages: e6501
ISSN: 1932-6203 (ISSN-L)
DOI: 10.1371/journal.pone.0006501
PMC: PMC2719581
OpenAlex: W2162988145
Cited by: 376
References: 71
Citations by year: 2026: 2 · 2025: 8 · 2024: 15 · 2023: 17 · 2022: 15 · 2021: 6 · 2020: 22 · 2019: 14 · 2018: 21 · 2017: 25 · 2016: 21 · 2015: 27 · 2014: 28 · 2013: 36 · 2012: 36
FWCI: 25.99
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by
creativecommons.org/licenses/by/4.0/ (unspecified)
Locations: PLoS ONE (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
eScholarship (California Digital Library) (submittedVersion, cc-by)
Figshare (submittedVersion, cc-by)
IUScholarWorks (Indiana University) (submittedVersion, cc-by)
Funders: Foundation for the National Institutes of Health (U01AG024904, AG024904)
Alzheimer's Association (U01 AG024904)
Bristol-Myers Squibb (U01 AG024904, AG024904)
Eli Lilly and Company (U01 AG024904, AG024904)
Pfizer (AG024904, U01 AG024904)
AstraZeneca
GlaxoSmithKline
Alzheimer's Disease Neuroimaging Initiative (3U01AG024904-03S5, ADNI U01 AG024904-01, U01AG024904, AG024904)
Novartis Pharmaceuticals Corporation (U01 AG024904, AG024904)
Northern California Institute for Research and Education (U01 AG024904)
Vanda Pharmaceuticals
Elan (U01 AG024904)
Eisai (U01 AG024904, AG024904)
National Institutes of Health (3u01ag024904-03s5, U01-AG024904, AG024904, ADNI U01 AG024904)
U.S. Food and Drug Administration
University of California, Los Angeles
University of California, San Diego
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging (U01-AG-024904, U01 AG024904-01, AG 024904, 3U01AG024904-03S5, U19AG010483, U24AG021886, 3U01AG024904)
National Institute of Biomedical Imaging and Bioengineering (U01 AG024904, AG024904)
National Center for Research Resources (U24RR021992, FBIRN U24-RR021992, RR021992, P20RR020837, TIGC-P20 RR020837-01, U01 AG024904)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
Keywords: Alzheimer's disease, hippocampal atrophy, genetic susceptibility, genome-wide association study, quantitative traits, apolipoprotein E, TOMM40, ephrin-A5, CAND1, MAGI2, arsB, single nucleotide polymorphisms, MRI phenotypes, sporadic Alzheimer's disease, ADNI
MeSH terms: Adult, Alzheimer Disease, Female, Hippocampus, Humans, Magnetic Resonance Imaging, Male, Case-Control Studies, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Quantitative Trait Loci, Genome-Wide Association Study

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Hippocampal Atrophy as a Quantitative Trait in a Genome-Wide Association Study Identifying Novel Susceptibility Genes for Alzheimer's Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks